Literature DB >> 27453416

miR-338-3p suppresses epithelial-mesenchymal transition and metastasis in human nonsmall cell lung cancer.

W Hong-Yuan1, C Xiao-Ping1.   

Abstract

OBJECTIVES: MicroRNAs are important modulators of the cellular epithelial-mesenchymal transition (EMT) process and are associated with metastasis in human nonsmall cell lung cancer (NSCLC). In this study, we tried to investigate the role of miR-338-3p in NSCLC cells.
MATERIALS AND METHODS: Real-time polymerase chain reaction was applied to quantify the expression levels of miR-338-3p, as well as EMT-associated molecules in NSCLC cells. Wound healing and transwell assays were performed to evaluate the migration and invasion capacities, respectively. Dual-luciferase reporter assay was finally performed to determine the targeting of zinc finger E-box-binding protein 2 (ZEB2) by miR-338-3p.
RESULTS: We found that miR-338-3p was significantly reduced in NSCLC cell lines. Forced expression of miR-338-3p in A549 cells led to the suppression of migration/invasion capacity and inhibition of epithelial markers. In addition, we proved that miR-338-3p could directly target ZEB2.
CONCLUSIONS: In general, we summarized that miR-338-3p could inhibit EMT and metastasis of human NSCLC cells, which probably via directly targeting ZEB2 expression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 27453416     DOI: 10.4103/0019-509X.186569

Source DB:  PubMed          Journal:  Indian J Cancer        ISSN: 0019-509X            Impact factor:   1.224


  5 in total

1.  MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.

Authors:  Guo-Qing Sui; Dan Fei; Feng Guo; Xi Zhen; Qiang Luo; Shuai Yin; Hui Wang
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

2.  MicroRNA-598 inhibits the proliferation and invasion of non-small cell lung cancer cells by directly targeting ZEB2.

Authors:  Xiangdong Tong; Peng Su; Haitao Yang; Fusheng Chi; Lin Shen; Xiao Feng; Hongqian Jiang; Xiuchun Zhang; Zhenyuan Wang
Journal:  Exp Ther Med       Date:  2018-10-03       Impact factor: 2.751

3.  MicroRNA-100 functions as a tumor suppressor in cervical cancer via downregulating the SATB1 expression and regulating AKT/mTOR signaling pathway and epithelial-to-mesenchymal transition.

Authors:  Cuiping Huang; Xiaobo Qin; Na Zhao; Huijing Jin; Shuangjun Zhang; Haiyan Yang
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

4.  MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.

Authors:  Huiguo Shan; Xuefeng Zhou; Chuanjun Chen
Journal:  Mol Med Rep       Date:  2019-06-03       Impact factor: 2.952

5.  MiR-338-3p improved lung adenocarcinoma by AKAP12 suppression.

Authors:  Jin Chang; Shuo Liu; Baowei Li; Zhongchao Huo; Xiaomin Wang; Hui Zhang
Journal:  Arch Med Sci       Date:  2019-12-19       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.